# A Phase I Study of High Dose Simvastatin in Patients With Gastrointestinal Tract Cancer Who Failed to Standard Chemotherapy

> **NCT03086291** · PHASE1 · UNKNOWN · sponsor: **Samsung Medical Center** · enrollment: 9 (estimated)

## Conditions studied

- Stomach Cancer

## Interventions

- **DRUG:** Simvastatin

## Key facts

- **NCT ID:** NCT03086291
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-01-04
- **Primary completion:** 2020-09
- **Final completion:** 2020-12
- **Target enrollment:** 9 (ESTIMATED)
- **Last updated:** 2019-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03086291

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03086291, "A Phase I Study of High Dose Simvastatin in Patients With Gastrointestinal Tract Cancer Who Failed to Standard Chemotherapy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03086291. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*